World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
129
Citations
101567
World Ranking
2522
National Ranking
1420

Overview

Philip J. Mease is affiliated with the University of Washington in the United States and has contributed extensively to research in medicine, with a strong focus on rheumatology and immunology. Their work intersects multiple subfields including hematology, psychiatry and mental health, and economics and econometrics, reflecting a multidisciplinary approach to complex health conditions.

Their research primarily covers topics related to spondyloarthritis studies and treatments, psoriasis treatment and pathogenesis, rheumatoid arthritis research and therapies, and autoimmune and inflammatory disorders. Additional topics addressed in their work include fibromyalgia and chronic fatigue syndrome research, health systems and economic evaluations, quality of life, and dermatology and skin diseases.

The most frequent venues for their publications are:

  • Annals of the Rheumatic Diseases
  • The Journal of Rheumatology
  • Lara D. Veeken
  • Rheumatology and Therapy
  • RMD Open

Philip J. Mease has collaborated with a number of researchers, often co-authoring with:

  • Laura C. Coates
  • Dafna D. Gladman
  • Iain B. McInnes
  • Alexis Ogdie
  • Joseph F. Merola

Among their recent publications are:

  • "Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021," published in 2022 in Nature Reviews Rheumatology
  • "Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial," published in 2020 in The Lancet
  • "Psoriatic arthritis," published in 2021 in Nature Reviews Disease Primers
  • "Secukinumab versus adalimumab for treatment of active psoriatic arthritis (EXCEED): a double-blind, parallel-group, randomised, active-controlled, phase 3b trial," published in 2020 in The Lancet
  • "EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update," published in 2024 in Annals of the Rheumatic Diseases

Their scientific contributions have centered on advancing understanding and treatment options for inflammatory and autoimmune diseases, particularly psoriatic arthritis. The emphasis on clinical trials and treatment guidelines in their publications highlights their role in bridging research and clinical application.

Best Publications

  • 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

    Daniel Aletaha;Tuhina Neogi;Alan J. Silman;Julia Funovits

  • The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity.

    Frederick Wolfe;Daniel J. Clauw;Mary Ann Fitzcharles;Don L. Goldenberg

  • Classification criteria for psoriatic arthritis: Development of new criteria from a large international study

    William Taylor;Dafna Gladman;Philip Helliwell;Antonio Marchesoni

  • Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial

    Philip J Mease;Bernard S Goffe;James Metz;Ann VanderStoep

  • Etanercept Therapy in Rheumatoid Arthritis: A Randomized, Controlled Trial

    Larry W. Moreland;Michael H. Schiff;Scott W. Baumgartner;Elizabeth A. Tindall

  • Psoriatic arthritis: epidemiology, clinical features, course, and outcome

    D D Gladman;C Antoni;P Mease;D O Clegg

  • 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria

    Frederick Wolfe;Daniel J. Clauw;Mary Ann Fitzcharles;Don L. Goldenberg;Don L. Goldenberg

  • Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia

    Frederick Wolfe;Daniel J. Clauw;Mary Ann Fitzcharles;Don L. Goldenberg

  • Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression

    Philip J. Mease;Alan J. Kivitz;Francis X. Burch;Evan L. Siegel

  • Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: Results of a double‐blind, randomized, placebo‐controlled trial

    Philip P.J. Mease;Dafna D.D. Gladman;Christopher C.T. Ritchlin;Eric E.M. Ruderman

  • Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010

    D. E. Furst;E. C. Keystone;J. Braun;F. C. Breedveld

  • Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis

    Laura C. Coates;Arthur Kavanaugh;Philip J. Mease;Enrique R. Soriano

  • Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2) : a randomised, double-blind, placebo-controlled, phase 3 trial

    Iain B McInnes;Philip J Mease;Bruce Kirkham;Arthur Kavanaugh

  • Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial.

    Leslie J. Crofford;Michael C. Rowbotham;Philip J. Mease;I. Jon Russell

  • Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis.

    Philip J. Mease;Iain B. McInnes;Bruce Kirkham;Arthur Kavanaugh

  • Golimumab, a new human tumor necrosis factor alpha antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty-four-week efficacy and safety results of a randomized, placebo-controlled study.

    Arthur Kavanaugh;Iain McInnes;Philip Mease;Gerald G. Krueger

  • Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: findings of a fifty-two-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.

    Edward Keystone;Désireé Van Der Heijde;David Mason;Robert Landewé

  • Treatment recommendations for psoriatic arthritis

    C. T. Ritchlin;A. Kavanaugh;D. D. Gladman;P. J. Mease

  • Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment.

    Philip Mease

  • Epidemiology of psoriatic arthritis in the population of the United States.

    Joel M. Gelfand;Dafna D. Gladman;Philip J. Mease;Nana Smith

Frequent Co-Authors

Dafna D. Gladman
Dafna D. Gladman Toronto Western Hospital
Arthur Kavanaugh
Arthur Kavanaugh University of California, San Diego
Philip S. Helliwell
Philip S. Helliwell University of Leeds
Christopher T. Ritchlin
Christopher T. Ritchlin University of Rochester Medical Center
Vibeke Strand
Vibeke Strand Stanford University
Iain B. McInnes
Iain B. McInnes University of Glasgow
Oliver FitzGerald
Oliver FitzGerald University College Dublin
Désirée van der Heijde
Désirée van der Heijde Leiden University Medical Center
Alice B. Gottlieb
Alice B. Gottlieb Icahn School of Medicine at Mount Sinai
Robert Landewé
Robert Landewé University of Amsterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens up numerous possibilities beyond becoming a doctor. Many students consider online degrees that offer flexibility and diverse career outcomes. For those already working as registered nurses, online rn to bsn programs without clinicals provide an accessible way to earn a bachelor’s degree while balancing work and life demands.

If your interests are in advancing further, adn to np bridge programs help registered nurses achieve nurse practitioner status with a flexible, online curriculum. These advanced roles often lead to higher salaries and greater autonomy in patient care.

Alternatively, non-clinical roles are also growing in demand. For those interested in nutrition, online nutrition degrees offer pathways into wellness coaching, food science, and community health education. Healthcare administration is another critical area, with leadership opportunities accessible through online mha programs cahme accredited by top industry bodies.

These educational routes ensure that students can align their studies with their career interests, whether in direct patient care, wellness, or health management.

Best Scientists Citing Philip J. Mease

Trending Scientists